- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Forcefield Therapeutics Ltd.
Headquarters: London, United Kingdom
Website: https://forcefieldtx.com/
Year Founded: 2022
Status: Private
BioCentury | Oct 17, 2023
Management Tracks
Allogene named Geoffrey Parker as CFO
Plus: Summit hires Manmeet Soni as COO, and updates from SwanBio, DBV, Lyra and EyePoint
BioCentury | Sep 27, 2023
Management Tracks
Syncona-backed Forcefield names Novartis vet Tsai CEO
Plus: PureTech hires Arix CEO Lyne and updates from InterVenn, Veracyte, Arcutis, Strata, Sanotize, Caribou, Mati
BioCentury | Nov 21, 2022
Management Tracks
Sandoz’ Francis to take the helm at Teva
Plus: Devey becomes CMO at Quell, and updates from Diadem, Pfizer and more
BioCentury | Sep 8, 2022
Discovery & Translation
An inroad to bunyaviruses; plus a gene therapy for tyrosinemia and more
BioCentury’s roundup of translational news
BioCentury | May 26, 2022
Management Tracks
Ex-Editas CEO Bosley among Advent’s new hires
U.K.-based VC taps Bosley, BioMotiv’s Jindal as it builds U.S. team; hires Syncona’s Schmidt in U.K.
BioCentury | Apr 27, 2022
Deals
April 26 Quick Takes: CD24 will be new focus of Forty Seven founders as Stanford spinout Pheast debuts
Plus Nkarta follows breakthrough data with $200M raise, and updates from Epitopea, Forcefield and
Items per page:
1 - 6 of 6